Shanxi's "Johor" Yangtze River Delta promotes the development of key industries

2022 Shanxi Governor Triangle (Nanjing) key industry promotion and docking session. Xinhuanet

On June 27, 2022 Shanxi Governor Triangle (Nanjing) key industry promotion and docking meeting was held in Nanjing, Jiangsu Province.

At the meeting, the relevant provincial departments, local governments and transformation comprehensive reform demonstration zones, Taixin integrated economic zones, and the provincial modern pharmaceutical industry chain "chain owner" enterprise Zhendong Group, Sinopharm Group Weichida Pharmaceutical Co., Ltd. Bao Pharmaceutical Group and others made specific recommendations.

Tang Zhiping, a member of the Party Group and Deputy Governor of the People's Government of Shanxi Province, said that in recent years, exchanges and cooperation between Shanxi and the Yangtze River Delta have continued to deepen. As the first large -scale investment promotion activity in our province this year, this time for the Yangtze River Delta, it has launched a long triangle and launched a long board. The investment promotion aims to give play to the advantages of the two parties in modern pharmaceutical and cultural tourism, and in -depth promotion of the industrial chain supply chain exchanges and cooperation, so that more entrepreneurs pay attention to Shanxi and invest in Shanxi. Today, Shanxi is in a critical period of high -quality development. Facing major policy opportunities, comparative advantages, more prominent advantages, and continuous optimization of the business environment. This time the key industry promotion and docking meeting provided platforms and carriers for strengthening exchanges and cooperation in Shanxi and the Yangtze River Delta, and warmly welcomed the Yangtze River Delta entrepreneurs to invest in Jinye and win -win development. , Invest in hometown.

2022 Shanxi Governor Triangle (Nanjing) key industry promotion and docking session. Xinhuanet

In terms of strategic emerging industries, Shanxi Province implements support policies such as 0.3 yuan per kWh electricity price mechanism to further promote the development of related industries. In 2021, the revenue of the pharmaceutical industry enterprise in Shanxi Province was 25.14 billion yuan. In 2022, it promoted the construction of six key projects with a total investment of 1.521 billion yuan to further enhance the stability and competitiveness of the industrial chain.

A docking will gather related companies in Shanxi and the Yangtze River Delta to develop together. In order to make the docking more effective, the Shanxi Provincial Investment Promotion Bureau and other relevant units continue to do project docking and tracking, and establish a work ledger for projects with preliminary cooperation intentions; Create core advantages.

"Shanxi Province will continue to improve the stability and competitiveness of the industrial chain around the 'pharmaceutical raw materials -pharmaceutical research and development -pharmaceutical manufacturing' chain." The annual output of Chinese medicinal materials such as Qiao, Scutellaria baicalensis, and Codonopsis is high. At present, the province has initially formed the upstream pharmaceutical intermediate and raw medicine manufacturing links with the National Medicine Group Weichida Pharmaceutical Co., Ltd. Industry is the core of midstream pharmaceutical development and downstream drug manufacturing.

2022 Shanxi Governor Triangle (Nanjing) key industry promotion and docking session. Xinhuanet

"The company has now formed a complete entire industry chain from the middle to the finished medicine, with complete categories and rich product lines. I hope that companies in the Yangtze River Delta region will cooperate in depth in the industrial chain, supplementary chain, and extension chain in the Yangtze River Delta region. Dividend. "Sinica's" chain owner "enterprise -Sin Pharmaceutical Group Weichida Pharmaceutical Co., Ltd. chief engineer An Xuefei said.

Lei Zhenhong, vice president of Zhendong Group, said that Zhendong Group will play the leading role of the "chain owner" enterprise in the modern pharmaceutical industry chain in Shanxi Province, and uses various forms such as the processing of Chinese medicinal materials, pharmaceutical production, and packaging enterprises introduced. Help, and actively promote the construction of traditional Chinese medicine research and development platforms, carry out technical research, and increase product added value.

Source: Xinhuanet

##

Graphic production: Shanxi Radio and Television Finance Media

Want to know more exciting content, come and follow Shanxi Radio and Television Railway Media

- END -